EMIS.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 spal. 2023 @ 18:29):

Stats
Šios dienos apimtis	646 116
Vidutinė apimtis	929 131
Rinkos kapitalizacija	1.23B
EPS	£0 ( 2023-09-06 )
Kita pelno data	( £0 ) 2024-05-23
Last Dividend	£21.10 ( 2023-06-15 )
Next Dividend	£0 ( N/A )
P/E	40.89
ATR14	£9.82 (0.51%)

Tūris Koreliacija

Ilgas: 0.10 (neutral)

Trumpas: 0.14 (neutral)

Signal:(63.039) Neutral

EMIS Group PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

EMIS Group PLC Koreliacija - Valiuta/Žaliavos

-0.43
( neutral )

0.42
( neutral )

0.53
( weak )

-0.18
( neutral )

0.15
( neutral )

0.45
( neutral )

EMIS Group PLC Finansinės ataskaitos

Annual	2022
Pajamos:	£175.37M
Bruto pelnas:	£162.47M (92.64 %)
EPS:	£0.530

FY	2022
Pajamos:	£175.37M
Bruto pelnas:	£162.47M (92.64 %)
EPS:	£0.530

FY	2021
Pajamos:	£168.23M
Bruto pelnas:	£151.97M (90.34 %)
EPS:	£0.462

FY	2020
Pajamos:	£159.45M
Bruto pelnas:	£139.12M (87.25 %)
EPS:	£0.481

Financial Reports:

No articles found.

EMIS Group PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£17.60 (N/A)	£0 (N/A)	£21.10 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

EMIS Group PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.22 - Stable (4.47%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£5.60	2010-09-22
Last Dividend	£21.10	2023-06-15
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	27	--
Total Paid Out	£308.10	--
Avg. Dividend % Per Year	1.42%	--
Score	4.57	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.22
Div. Directional Score	9.09	--

Next Divdend (Est)
(2024-10-10)

£0 Estimate 3.68 %

Dividend Stability

0.29 Very Poor

Dividend Score

4.57

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£27.10	3.18%
2019	£29.80	3.24%
2020	£31.60	2.82%
2021	£33.60	3.03%
2022	£35.20	2.65%
2023	£21.10	1.13%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SEQI.L	Dividend Knight	2023-07-27	Quarterly	10	3.85%
ICGC.L	Dividend Knight	2023-09-14	Annually	15	1.80%
BISI.L	Dividend Knight	2024-01-04	Annually	32	2.05%
WTB.L	Dividend Knight	2023-05-25	Annually	33	0.87%
NTV.L	Dividend Knight	2023-07-20	Semi-Annually	25	4.03%
EMG.L	Dividend King	2023-08-10	Semi-Annually	31	3.60%
SPT.L	Dividend Knight	2023-08-10	Semi-Annually	32	1.51%
JD.L	Dividend Knight	2023-12-07	Annually	28	0.21%
BUT.L	Dividend King	2023-08-03	Quarterly	49	1.28%
PNL.L	Dividend Knight	2023-08-24	Quarterly	41	0.75%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.189	1.500	6.22	9.33	[0 - 0.5]
returnOnAssetsTTM	0.148	1.200	5.08	6.10	[0 - 0.3]
returnOnEquityTTM	0.245	1.500	8.39	10.00	[0.1 - 1]
payoutRatioTTM	0.669	-1.000	3.31	-3.31	[0 - 1]
currentRatioTTM	1.210	0.800	8.95	7.16	[1 - 3]
quickRatioTTM	0.649	0.800	-0.887	-0.709	[0.8 - 2.5]
cashRatioTTM	0.649	1.500	7.50	10.00	[0.2 - 2]
debtRatioTTM	0.0194	-1.500	9.68	-10.00	[0 - 0.6]
interestCoverageTTM	52.25	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.722	2.00	9.76	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.611	2.00	9.69	10.00	[0 - 20]
debtEquityRatioTTM	0.0306	-1.500	9.88	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.926	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.158	1.000	8.84	8.84	[0.1 - 0.6]
cashFlowToDebtRatioTTM	10.59	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.780	0.800	8.13	6.51	[0.5 - 2]
Total Score				12.95

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	37.07	1.000	6.36	0	[1 - 100]
returnOnEquityTTM	0.245	2.50	8.97	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.611	2.00	9.80	10.00	[0 - 30]
dividendYielPercentageTTM	2.21	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.722	2.00	9.76	10.00	[0 - 30]
payoutRatioTTM	0.669	1.500	3.31	-3.31	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.263	1.000	5.91	0	[0.1 - 0.5]
Total Score				5.22

EMIS Group PLC

EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web, which enables patients to order repeat medication online and track progress from order to home delivery; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.